Skip to main content
Erschienen in: Indian Journal of Pediatrics 10/2016

13.01.2016 | Review Article

When to Suspect and How to Diagnose Mitochondrial Disorders?

verfasst von: Sergei Korenev, Andrew A. M. Morris

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Disorders of the mitochondrial respiratory chain are an exceedingly diverse group. The clinical features can affect any tissue or organ and occur at any age, with any mode of inheritance. The diagnosis of mitochondrial disorders requires knowledge of the clinical phenotypes and access to a wide range of laboratory techniques. A few syndromes are associated with a specific genetic defect and in these cases it is appropriate to proceed directly to an appropriate test of blood or urine. In most cases, however, the best strategy starts with biochemical and histochemical studies on a muscle biopsy. Appropriate molecular genetic studies can then be chosen, based on these results and the clinical picture. Unfortunately, there is currently limited availability of respiratory chain studies in India. Exome sequencing is undertaken increasingly often; without preceding mitochondrial studies, this can lead to misleading results.
Literatur
1.
Zurück zum Zitat Dhillon VS, Fenech M. Mutations that affect mitochondrial functions and their association with neurodegenerative diseases. Mutat Res Rev Mutat Res. 2014;759:1–13.CrossRefPubMed Dhillon VS, Fenech M. Mutations that affect mitochondrial functions and their association with neurodegenerative diseases. Mutat Res Rev Mutat Res. 2014;759:1–13.CrossRefPubMed
2.
Zurück zum Zitat Lindroos MM, Majamaa K, Tura A, et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction. Diabetes. 2009;58:543–9.CrossRefPubMedPubMedCentral Lindroos MM, Majamaa K, Tura A, et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction. Diabetes. 2009;58:543–9.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol. 2013;5:a021220.CrossRefPubMedPubMedCentral Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol. 2013;5:a021220.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Rahman S, Hanna MG. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry. 2009;80:943–53.CrossRefPubMed Rahman S, Hanna MG. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry. 2009;80:943–53.CrossRefPubMed
7.
Zurück zum Zitat DiMauro S, Hirano M. MELAS. In: Pagon RA, Adam MP, Ardinger HH, editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2015. 2001 Feb 27 [updated 2013 Nov 21]. DiMauro S, Hirano M. MELAS. In: Pagon RA, Adam MP, Ardinger HH, editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2015. 2001 Feb 27 [updated 2013 Nov 21].
8.
Zurück zum Zitat Haas RH, Parikh S, Falk MJ, et al; Mitochondrial Medicine Society’s Committee on Diagnosis. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94:16–37. Haas RH, Parikh S, Falk MJ, et al; Mitochondrial Medicine Society’s Committee on Diagnosis. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94:16–37.
9.
Zurück zum Zitat Davis RL, Liang C, Edema-Hildebrand F, et al. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology. 2013;81:1819–26.CrossRefPubMed Davis RL, Liang C, Edema-Hildebrand F, et al. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology. 2013;81:1819–26.CrossRefPubMed
10.
Zurück zum Zitat Suomalainen A, Elo JM, Pietiläinen KH, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 2011;10:806–18.CrossRefPubMed Suomalainen A, Elo JM, Pietiläinen KH, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 2011;10:806–18.CrossRefPubMed
11.
Zurück zum Zitat Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev. 2010;16:129–35.CrossRefPubMed Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev. 2010;16:129–35.CrossRefPubMed
12.
13.
Zurück zum Zitat Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet. 2007;81:857–62.CrossRefPubMedPubMedCentral Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet. 2007;81:857–62.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Scheper GC, van der Klok T, van Andel RJ, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet. 2007;39:534–9.CrossRefPubMed Scheper GC, van der Klok T, van Andel RJ, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet. 2007;39:534–9.CrossRefPubMed
16.
Zurück zum Zitat Baker PR, Friederich MW, Swanson MA, et al. Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain. 2014;137:366–79.CrossRefPubMed Baker PR, Friederich MW, Swanson MA, et al. Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain. 2014;137:366–79.CrossRefPubMed
17.
Zurück zum Zitat Wortmann SB, Duran M, Anikster Y, et al. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J Inherit Metab Dis. 2013;36:923–8.CrossRefPubMed Wortmann SB, Duran M, Anikster Y, et al. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J Inherit Metab Dis. 2013;36:923–8.CrossRefPubMed
19.
Zurück zum Zitat Lara MC, Valentino ML, Torres-Torronteras J, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep. 2007;27:151–63.CrossRefPubMed Lara MC, Valentino ML, Torres-Torronteras J, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep. 2007;27:151–63.CrossRefPubMed
20.
Zurück zum Zitat Bowron A, Frost R, Powers VE, et al. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis. J Inherit Metab Dis. 2013;36:741–6.CrossRefPubMed Bowron A, Frost R, Powers VE, et al. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis. J Inherit Metab Dis. 2013;36:741–6.CrossRefPubMed
21.
Zurück zum Zitat Rollins S, Prayson RA, McMahon JT, et al. Diagnostic yield muscle biopsy in patients with clinical evidence of mitochondrial cytopathy. Am J Clin Pathol. 2001;116:326–30.CrossRefPubMed Rollins S, Prayson RA, McMahon JT, et al. Diagnostic yield muscle biopsy in patients with clinical evidence of mitochondrial cytopathy. Am J Clin Pathol. 2001;116:326–30.CrossRefPubMed
22.
Zurück zum Zitat Rodenburg RJ. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis. 2011;34:283–92.CrossRefPubMed Rodenburg RJ. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis. 2011;34:283–92.CrossRefPubMed
23.
Zurück zum Zitat Taylor RW, Pyle A, Griffin H, et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. J Am Med Assoc. 2014;312:68–77.CrossRef Taylor RW, Pyle A, Griffin H, et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. J Am Med Assoc. 2014;312:68–77.CrossRef
Metadaten
Titel
When to Suspect and How to Diagnose Mitochondrial Disorders?
verfasst von
Sergei Korenev
Andrew A. M. Morris
Publikationsdatum
13.01.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-015-1932-y

Weitere Artikel der Ausgabe 10/2016

Indian Journal of Pediatrics 10/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.